Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
58
NCT00615966
Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2008
Completion: Feb 28, 2010